Effect of IL-10 on LOX-1 expression, signalling and functional activity: An atheroprotective response

Diabetes and Vascular Disease Research

Volumn 10, Issue 5, 2013, Pages 442-451

  Arjuman, Albina ^a   Chandra, Nimai C ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

atherosclerosis; Interleukin 10; lectin like oxidized low density lipoprotein receptor 1; oxidized low density lipoprotein

Indexed keywords

INTERLEUKIN 10; NITRIC OXIDE; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1;

ARTICLE; CONTROLLED STUDY; HAPLOTYPE; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ATHEROSCLEROSIS; INTERLEUKIN-10; LECTIN-LIKE OXIDIZED LOW-DENSITY LIPOPROTEIN RECEPTOR-1; OXIDIZED LOW-DENSITY LIPOPROTEIN;

ATHEROSCLEROSIS; CELLS, CULTURED; ENDOTHELIAL CELLS; HUMANS; INTERLEUKIN-10; LIPOPROTEINS, LDL; MACROPHAGES; SCAVENGER RECEPTORS, CLASS E; SIGNAL TRANSDUCTION;

EID: 84882377436     PISSN: 14791641     EISSN: 17528984     Source Type: Journal    
DOI: 10.1177/1479164113489042     Document Type: Article

References (27)

1. Daugherty A, Roselaar SE. Lipoprotein oxidation as a mediator of atherogenesis: insights from pharmacological studies. Cardiovasc Res. 1995 ; 29: 297-311
2. Galle J, Wanner C. Modification of lipoproteins in uremia: oxidation, glycation and carbamoylation. Miner Electrolyte Metab. 1999 ; 25: 2630-2668
3. Paoletti R, Gotto AM, Hajjar DP. Inflammation in atherosclerosis and implications for therapy. Circulation. 2004 ; 109: III-20 - III-26
4. Sawamura T, Kume N, Aoyama T, et al. An endothelial receptor for oxidized low-density lipoprotein. Nature. 1997 ; 386: 73-77
5. Xiu-ping C, Guan-hua DU. Lectin-like oxidized low-density lipoprotein receptor-1: protein, ligands, expression and pathophysiological significance. Chin Med J. 2007 ; 120: 421-426
6. Mehta JL, Chen J, Hermonat PL, et al. Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders. Cardiovasc Res. 2006 ; 69: 36-45
7. Murphy JE, Vohra RS, Dunn S, et al. Oxidised LDL internalization by the LOX-1 scavenger receptor is dependent on a novel cytoplasmic motif and is regulated by dynamin-2. J Cell Sci. 2008 ; 121: 2136-2147
8. Zhu H, Xia M, Hou M, et al. Ox-LDL plays dual effect in modulating expression of inflammatory molecules through LOX-1 pathway in human umbilical vein endothelial cells. Front Biosci. 2005 ; 10: 2585-2595
9. Terkeltaub RA. IL-10: an 'immunologic scalpel' for atherosclerosis?. Arterioscler Thromb Vasc Biol. 1999 ; 19: S2823 - S2825
10. Tedgui A, Mallat Z. Anti-inflammatory mechanisms in the vascular wall. Circ Res. 2001 ; 88: 877-887
11. Halvorsen B, Waehre T, Schilz H, et al. Interleukin-10 enhances the oxidized LDL-induced foam cell formation of macrophages by antiapoptotic mechanisms. J Lipid Res. 2005 ; 46: 211-219
12. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955 ; 34: 1345-1353
13. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1972 ; 72: 248-254
14. Leiro J, Iglesias R, Parama A, et al. Effect of Tetramicra brevifilum (Microspora) infection on respiratory-burst responses of turbot (Scophthalmus maximus L.) phagocytes. Fish Shellfish Immunol. 2001 ; 11: 639-652
15. Azenabor AA, Kennedy P, York J. Free intracellular Ca2+ regulates lipopolysaccharide induction of iNOS in human macrophages. Immunobiology. 2009 ; 214: 143-152
16. Schwende H, Fitzke E, Ambs P, et al. Difference in the state of differentiation of THP-1 cells induced by phorbol ester and 1,25- dihydroxyvitamin D3. J Leukoc Biol. 1996 ; 59: 555-561
17. Yoshida H, Quehenberger O, Kondratenko N, et al. Minimally oxidized low-density lipoprotein increases expression of scavenger receptor A, CD36, and macrosialin in resident mouse peritoneal macrophages. Arterioscler Thromb Vasc Biol. 1998 ; 18: 794-802
18. Smirnova IV, Kajstura M, Sawamura T, et al. Asymmetric dimethylarginine upregulates LOX-1 in activated macrophages: the role in foam cell formation. Am J Physiol Heart Circ Physiol. 2004 ; 287: H782 - H790
19. Reiling N, Ulmer AJ, Duchrow M, et al. Nitric oxide synthase: mRNA expression of different isoforms in human monocytes/macrophages. Eur J Immunol. 1994 ; 24: 1941-1944
20. Mango R, Biocca S, del Vecchio F, et al. In vivo and in vitro studies support that a new splicing isoform of OLR1 gene is protective against acute myocardial infarction. Circ Res. 2005 ; 97: 152-158
21. Ignarro RJ. Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu Rev Pharmacol Toxicol. 1990 ; 30: 535-560
22. Fleming I, Mohamed A, Galle J, et al. Oxidized low-density lipoprotein increases superoxide production by endothelial nitric oxide synthase by inhibiting PKCα. Cardiovasc Res. 2005 ; 65: 897-906
23. Vecchione L, Diano L, Campagnolo L, et al. Functional characterization and expression analysis of novel alternative splicing isoforms of OLR1 gene during mouse embryogenesis. Gene. 2012 ; 491: 5-12
24. Cominacini L, Pasini AF, Garbin U, et al. Nebivolol and its 4-keto derivative increase nitric oxide in endothelial cells by reducing its oxidative inactivation. J Am Coll Cardiol. 2003 ; 42: 1838-1844
25. Bittner O, Gal S, Pinchuk I, et al. Copper-induced peroxidation of liposomal palmitoyllinoleoyl phosphatidylcholine (PLPC), effect of antioxidants and its dependence on the oxidative stress. Chem Phys Lipids. 2002 ; 114: 81-98
26. Ramos P, Gieseg SP, Schuster B, et al. Effect of temperature and phase transition on oxidation resistance of low density lipoprotein. J Lipid Res. 1995 ; 36: 2113-2128
27. Yagi K. Lipid peroxide and human disease. Chem Phys Lipids. 1987 ; 45: 337-351